Results 191 to 200 of about 2,092,591 (384)
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He+8 more
wiley +1 more source
An Improved Method for the Calibration of Continuously Recorded Dye Dilution Curves
R Emanuel, W. W. Lacy, Elliot V. Newman
openalex +1 more source
XXVIII.—The changes of volume due to dilution of aqueous solutions [PDF]
E. B. H. Wade
openalex +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia+9 more
wiley +1 more source
Metastasis; Other Side of the Coin
Aftab Ahmad eChattha+2 more
doaj +1 more source
Thermal Dilution Curves in the Intact Animal
Allan V. N. Goodyer+3 more
openalex +1 more source
Current trends in single‐cell RNA sequencing applications in diabetes mellitus
Single‐cell RNA sequencing is a powerful approach to decipher the cellular and molecular landscape at a single‐cell resolution. The rapid development of this technology has led to a wide range of applications, including the detection of cellular and molecular mechanisms and the identification and introduction of novel potential diagnostic and ...
Seyed Sajjad Zadian+6 more
wiley +1 more source
The Relation of Serum Dilution and of Antigen Density to the Non-Specific Precipitations of Fowl Serum [PDF]
S. J. Schilling, G. S. Schilling
openalex +1 more source
Phenotypic plasticity in a newly established set of EGFR inhibitor‐adapted NSCLC cell lines during adaptation and in established cell lines. Here, we introduce novel sublines of the EGFR‐mutant non‐small cell lung cancer (NSCLC) cell lines HCC827 and HCC4006 adapted to the EGFR kinase inhibitors gefitinib (HCC827rGEFI2μm, HCC4006rGEFI1μm), erlotinib ...
Tharsagini V. Nanthaprakash+6 more
wiley +1 more source